Plasma Dehydroepiandrosterone Levels in HIV Infection

JAMA: The Journal of the American Medical Association

Volumn 261, Issue 8, 1989, Pages 1149-

  Merril, Carl R ^a   Harrington, Michael G ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRASTERONE;

ADULT; AGE; ANIMAL; BLOOD; CHILD; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER;

ADULT; AGE FACTORS; ANIMAL; CHILD; FEMALE; HIV SEROPOSITIVITY; HUMAN; PRASTERONE;

EID: 0024977374     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1989.03420080063018     Document Type: Letter

References (13)

1. Barrett-Connor E, Khaw K-T, Yen SSC. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med. 1986;315:1519-1524.
2. Rothenberg R, Woelfel M, Stoneburner R, et al. Survival with the acquired immunodeficiency syndrome. N Engl J Med. 1987;317:1297-1302.
3. Yamaji T, Ibayashi H. Plasma dehydroepiandrosterone sulfate in normal and pathological conditions. J Clin Endocrinol. 1969;29:273-278.
4. Bulbrook RD, Hayward JL, Spicer CC. Relation between urinary androgen and corticoid excretion and subsequent breast cancer. Lancet. 1971;2:395-398.
5. Brownsey B, Cameron EHD, Griffiths K, et al. Plasma dehydroepiandrosterone sulphate levels in patients with benign and malignant breast disease. Europ J Cancer Clin Oncol. 1972;8:131-137.
6. Schwartz AG. Inhibition of spontaneous breast cancer formation in female C3H (Avy/a) mice by long-term treatment with dehydroepiandrosterone. Cancer Res. 1979;39: 1129-1132.
7. Coleman DL, Schwizer RW, Leiter EH. Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes-obesity mutants and in aged normal mice. Diabetes. 1984;33:26-32.
8. Lucas JA, Ahmed SA, Casey ML, MacDonald PC. Prevention of autoantibody formation and prolonged survival in New Zealand Black/New Zealand White Fl mice fed dehydroepiandrosterone. J Clin Invest. 1985;75:2091-2093.
9. Nyce JW, Magee PN, Hard GC, Schwartz AG. Inhibition of 1,2-dimethylhydrazine-induced colon tumorigenesis in Balb/c mice by dehydroepiandrosterone. Carcinogenesis. 1984;5:57-62.
10. Schwartz AG, Tannen RH. Inhibition of 7,12-dimethylbenz[a]anthracene and urethane-induced lung tumor formation in A/J mice by long-term treatment with dehydroepiandrosterone. Carcinogenesis. 1981;2:1335-1337.
11. Pashko LL, Schwartz AG. Effect of food restriction, dehydroepiandrosterone, or obesity on the binding of 3H-7, 12-dimethylbenz[a]anthracene to mouse skin DNA. J Gerontol. 1983;38:8-12.
12. Henderson E, Schwartz AG, Pashko L, et al. Dehydroepiandrosterone and 16alpha-bromo-epiandrosterone: inhibitors of Epstein-Barr virus-induced transformation of human lymphocytes. Carcinogenesis. 1981;2:683-686.
13. Cutler GB, Glenn MJ, Bush M, et al. Adrenarche: a survey of rodents, domestic animals and primates. Endocrinology. 1978;103:2112-2118.